Intronic genomic breakpoints originated from the rearrangement of an AR-regulated gene with ERG—and in general from any somatic genomic aberration—represent cancer-specific sequences that could be used to selectively kill ERG-positive tumor cells. This evidence concerns the gene ERG and neoplasm.